Tag: US generics market

India's Sun Pharmaceutical on April 27 said it had agreed to buy women's healthcare firm Organon in a deal that values the US drugmaker at $11.75 billion. (AFP)
Posted in Business

Winds of change in Sun Pharma’s $11.75 billion Organon acquisition announcement

 April 28, 2026  Leave a Comment on Winds of change in Sun Pharma’s $11.75 billion Organon acquisition announcement

Sun Pharmaceutical Industries on Monday announced the $11.75 billion acquisition of Organon & Co., in a seemingly aggressive push into the US market that has…

Continue Reading